These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7179208)

  • 1. Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis.
    Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Nilsson E; Wilhelmsson S; Zetterquist S
    Thromb Res; 1982 Sep; 27(6):631-9. PubMed ID: 7179208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.
    Lindmarker P; Holmström M; Granqvist S; Johnsson H; Lockner D
    Thromb Haemost; 1994 Aug; 72(2):186-90. PubMed ID: 7831649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.
    Doyle DJ; Turpie AG; Hirsh J; Best C; Kinch D; Levine MN; Gent M
    Ann Intern Med; 1987 Oct; 107(4):441-5. PubMed ID: 3307582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.
    Walker MG; Shaw JW; Thomson GJ; Cumming JG; Thomas ML
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1189-92. PubMed ID: 3109574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi-Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis.
    Bratt GA; Törnebohm E; Johanson M; Aberg W; Granqvist S; Lockner D
    Acta Chir Scand Suppl; 1988; 543():96-100. PubMed ID: 2847465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities].
    Lopaciuk S; Misiak A; Wisławski S; Ciesielski L; Korzycki J; Judkiewicz L; Lewandowski K; Tokarz A; Kłoczko J; Bielawiec M
    Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):949-52. PubMed ID: 2104438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).
    Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D
    Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose heparin. A cause of hematoma of rectus abdominis.
    Tsapatsaris NP
    Arch Intern Med; 1991 Mar; 151(3):597-9. PubMed ID: 1845603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis.
    Arnesen H; Heilo A; Jakobsen E; Ly B; Skaga E
    Acta Med Scand; 1978; 203(6):457-63. PubMed ID: 352099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
    Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin treatment of deep venous thrombosis in 280 patients: symptoms related to dosage.
    Holm HA; Finnanger B; Hartmann A; Laerum F; Løhren O; Ruud TE; Stray N; Wolland T
    Acta Med Scand; 1984; 215(1):47-53. PubMed ID: 6695563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis.
    Hommes DW; Bura A; Mazzolai L; Büller HR; ten Cate JW
    Ann Intern Med; 1992 Feb; 116(4):279-84. PubMed ID: 1531108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin treatment. Comparison between intravenous and subcutaneous administration].
    Krähenbühl B; Simon CA; Bouvier CA; Schinas P; Hopf MA; Cochet B
    Schweiz Med Wochenschr; 1979 Sep; 109(36):1322-5. PubMed ID: 504973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.